[{"NetIncomeLossConverted_2_Q2_USD":-35187000.0,"NetIncomeLossConverted_1_Q2_USD":-19893000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":-32557000.0,"CommonStockSharesOutstanding_0_Q2_shares":43016501.0,"StockholdersEquity_0_Q2_USD":290874000.0,"Assets_0_Q2_USD":301020000.0,"CommonStockSharesConverted_0_Q2_shares":43016501.0,"Ticker":"SWTX","CIK":"1773427","name":"SPRINGWORKS THERAPEUTICS, INC.","OfficialName":"SpringWorks Therapeutics Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"2","uom":"USD","footnote":"nan","Market Cap":"2504354261.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200812"}]